SCHEMBL6533332

SCHEMBL6533332

O=C(O)/C=C/c1cc2c(cn1)NC(=O)CC2=O

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
ITGB3 P05106 1/20 0.33
ITGB1 P05556 1/20 0.33
ITGAV P06756 1/20 0.33
ITGA4 P13612 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
PKM P14618 1/20 0.32
KDM4E B2RXH2 2/20 0.32
BLM P54132 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
SMYD3 Q9H7B4 1/20 0.32
RAB9A P51151 1/20 0.31
CRBN Q96SW2 1/20 0.31
P4HTM Q9NXG6 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14785626 0.65 RXRA (0.59)
SCHEMBL14785625 0.65 RXRA (0.59)
SCHEMBL25242305 0.63 AHR (0.49) ALDH1A1MAPTPKMKDM4ENPSR1
SCHEMBL1093134 0.63 AHR (0.49) PDE3BPDE3AALDH1A1MAPTPKM
SCHEMBL1093132 0.63 AHR (0.49) PDE3BPDE3AALDH1A1MAPTPKM
SCHEMBL20417373 0.63 RXRA (0.65)
Hydrochloric Acid SCHEMBL1092481 0.62 AHR (0.47) PDE3BPDE3AALDH1A1MAPTPKM
Hydrochloric Acid SCHEMBL1092478 0.62 AHR (0.47) PDE3BPDE3AALDH1A1MAPTPKM
SCHEMBL3888550 0.61 ALDH1A1 (0.44) ALDH1A1MAPTPKMKDM4ERAB9A
SCHEMBL3888548 0.61 ALDH1A1 (0.44) ALDH1A1MAPTPKMKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY Affinium Pharmaceuticals, Inc. (CA) 2005-09-21 EP disclosed
WO-2004052890-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY AFFINIUM PHARMACEUTICALS, INC. (CA) 2004-06-24 WO disclosed